Opioid Addiction

Featured Article

Obama Administration Senior Policy Advisor and Addiction Expert on White House Initiative to Address the Opioid Crisis

Obama Administration Senior Policy Advisor and Addiction Expert on White House Initiative to Address the Opioid Crisis

On October 30, 2017, the Clinton Foundation's Health Matters Initiative held a panel event at the Johns Hopkins Bloomberg School of Public Health for the release of a report co-written by these 2 organizations, titled "The Opioid Epidemic - From Evidence to Impact."

Latest

Methadone vs Buprenorphine During Pregnancy and Risk for Neonatal Abstinence Syndrome

Methadone vs Buprenorphine During Pregnancy and Risk for Neonatal Abstinence Syndrome

Methadone exposure in utero was shown to increase the risk for neonatal abstinence syndrome compared with buprenorphine exposure.

Substance Use Disorder Rates Up in Childbearing Women

Substance Use Disorder Rates Up in Childbearing Women

Between 2005 and 2014, the prevalence of chronic conditions increased across all segments of the childbearing population, including substance use disorder.

FDA Approves Once-Monthly Buprenorphine Injection for Opioid Use Disorder

FDA Approves Once-Monthly Buprenorphine Injection for Opioid Use Disorder

In a press release issued November 30, 2017, the US Food and Drug Administration announced it has approved Sublocade, a once-monthly buprenorphine injection for moderate to severe opioid use disorder.

Immediate Access to Opioid Agonist Treatment Is Cost-Effective, Beneficial

Immediate Access to Opioid Agonist Treatment Is Cost-Effective, Beneficial

Immediate access to opioid agonist treatment for patients presenting with opioid use disorder may provide greater health benefits at less cost than observed standard of care.

FDA Grants Priority Review to Lofexidine for Management of Opioid Withdrawal Symptoms

FDA Grants Priority Review to Lofexidine for Management of Opioid Withdrawal Symptoms

US WorldMeds announced that the Food and Drug Administration has accepted for Priority Review the New Drug Application for lofexidine to manage the symptoms associated with opioid withdrawal and to facilitate completion of opioid discontinuation treatment.

Personalized Opioid Dosing Suggested Following Hysterectomy

Personalized Opioid Dosing Suggested Following Hysterectomy

Gynecologists prescribe about twice the amount of opioids than patients use after hysterectomy for benign, nonobstetric indications.

Extended-Release Naltrexone Injections Reduce Opioid Dependence

Extended-Release Naltrexone Injections Reduce Opioid Dependence

Compared with buprenorphine-naloxone, use of extended-release naltrexone maintained abstinence from heroin and other illicit substances at a similar rate.

Clinton Foundation's Recommendations to Address the Opioid Crisis

Clinton Foundation's Recommendations to Address the Opioid Crisis

The Clinton Foundation's Health Matters Initiative, in partnership with the Johns Hopkins Bloomberg School of Public Health, issued a report providing 49 recommendations under 10 topic areas on how to address the opioid crisis.

DEA Announces All Illicit Fentanyl Analogues Will Be Subject to Criminal Prosecution

DEA Announces All Illicit Fentanyl Analogues Will Be Subject to Criminal Prosecution

The announcement comes from the Department of Justice and will give the Drug Enforcement Agency the ability to take immediate action to stop illicit fentanyl from coming into the US.

Cannabis Use Associated With Relationship Between Pain and Negative Affect

Cannabis Use Associated With Relationship Between Pain and Negative Affect

Frequent cannabis users enrolled in a Medication-Assisted Treatment for opioid addiction exhibit greater associations between pain and negative affects compared with less-frequent users.

Opioid Manufacturers Providing Training for Clinicians

Opioid Manufacturers Providing Training for Clinicians

In an effort to halt the ongoing opioid addiction crisis, US regulators are requiring manufacturers to provide extensive training to doctors.

Prescription Drug Monitoring Programs: How Effective Are They?

Prescription Drug Monitoring Programs: How Effective Are They?

Although the registration to prescription drug monitoring programs (PDMPs) was shown to lead to statewide declines in high-risk opioid prescriptions, these declines were similar to those observed in non-PDMP registrants.

Motivational Interview Intervention Reduces Opioid Overdose

Motivational Interview Intervention Reduces Opioid Overdose

A motivational interviewing intervention delivered by trained counselors reduced the rate of opioid overdoses in participants with opioid use disorder.

FDA: Opioid Addiction Medication Should Not Be Withheld While Taking CNS Depressants

FDA: Opioid Addiction Medication Should Not Be Withheld While Taking CNS Depressants

A review of several published studies showed that the evidence did not support dose limitations or arbitrary caps of buprenorphine or methadone as a strategy to address benzodiazepine or other CNS depressant use in MAT-treated patients.

Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse

Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse

Narcan Nasal Spray, an opioid antagonist, is indicated for the reversal of known or suspected opioid overdose, including respiratory and/or central nervous system depression.

Illicit Fentanyl Linked to More Than Half of US Overdose Deaths

Illicit Fentanyl Linked to More Than Half of US Overdose Deaths

Fentanyl was detected in more than half of the 5152 opioid overdose deaths in 10 states from July through December of 2016.

Transdermal to Buccal Buprenorphine Transition

Transdermal to Buccal Buprenorphine Transition

Patients can be transitioned from transdermal to buccal formulations of buprenorphine within 12 hours of patch removal using the recommended buccal formulation titration doses and schedule.

New CDC Communication Campaign Addresses Opioid Epidemic

New CDC Communication Campaign Addresses Opioid Epidemic

The CDC is launching a communication campaign featuring accounts of people recovering from opioid use disorder, and those who have lost someone to opioid overdose, in an effort to fight the prescription overdose epidemic.

Opioid Use Low Among Veterans With Recent Traumatic Brain Injury Diagnosis

Opioid Use Low Among Veterans With Recent Traumatic Brain Injury Diagnosis

Opioid use was shown to be relatively low in veterans of Iraq and Afghanistan with recently diagnosed traumatic brain injuries, but approximately one-quarter of those who initiated opioids were chronic users.

Opioid Dependence Prevention Treatments Compared

Opioid Dependence Prevention Treatments Compared

Significantly less heroin cravings were reported in the extended-release naltrexone group and treatment satisfaction was also reported higher in this group compared to the buprenorphine-naloxone group.

Sign Up for Free e-Newsletters